Related references
Note: Only part of the references are listed.The lightning-fast quest for COVID vaccines - and what it means for other diseases
Philip Ball
NATURE (2021)
Cell Mechanical and Physiological Behavior in the Regime of Rapid Mechanical Compressions that Lead to Cell Volume Change
Anna Liu et al.
SMALL (2020)
CRISPR-engineered T cells in patients with refractory cancer
Edward A. Stadtmauer et al.
SCIENCE (2020)
Nanomedicines to Deliver mRNA: State of the Art and Future Perspectives
Itziar Gomez-Aguado et al.
NANOMATERIALS (2020)
Memory T cells: strategies for optimizing tumor immunotherapy
Qingjun Liu et al.
PROTEIN & CELL (2020)
An mRNA Vaccine against SARS-CoV-2-Preliminary Report
L. A. Jackson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Characteristics of anti-CD19 CAR T cell infusion products associated with efficacy and toxicity in patients with large B cell lymphomas
Qing Deng et al.
NATURE MEDICINE (2020)
Efficient and nontoxic biomolecule delivery to primary human hematopoietic stem cells using nanostraws
Ludwig Schmiderer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
High-throughput continuous-flow microfluidic electroporation of mRNA into primary human T cells for applications in cellular therapy manufacturing
Charles A. Lissandrello et al.
SCIENTIFIC REPORTS (2020)
CAR-NK cells: A promising cellular immunotherapy for cancer
Guozhu Xie et al.
EBIOMEDICINE (2020)
Instant labeling of therapeutic cells for multimodality imaging
Hossein Nejadnik et al.
THERANOSTICS (2020)
Purification of mRNA Encoding Chimeric Antigen Receptor Is Critical for Generation of a Robust T-Cell Response
Jessica B. Foster et al.
HUMAN GENE THERAPY (2019)
Genome Editing with mRNA Encoding ZFN, TALEN, and Cas9
Hong-Xia Zhang et al.
MOLECULAR THERAPY (2019)
Delivering the Messenger: Advances in Technologies for Therapeutic mRNA Delivery
Piotr S. Kowalski et al.
MOLECULAR THERAPY (2019)
Non-viral Delivery of Zinc Finger Nuclease mRNA Enables Highly Efficient In Vivo Genome Editing of Multiple Therapeutic Gene Targets
Anthony Conway et al.
MOLECULAR THERAPY (2019)
Adoptive Transfer of NKG2D CAR mRNA-Engineered Natural Killer Cells in Colorectal Cancer Patients
Lin Xiao et al.
MOLECULAR THERAPY (2019)
Intradermal delivery of modified mRNA encoding VEGF-A in patients with type 2 diabetes
Li-Ming Gan et al.
NATURE COMMUNICATIONS (2019)
Delivering Cas9/sgRNA ribonucleoprotein (RNP) by lentiviral capsid-based bionanoparticles for efficient 'hit-and-run' genome editing
Pin Lyu et al.
NUCLEIC ACIDS RESEARCH (2019)
Natural Killer Cells as Allogeneic Effectors in Adoptive Cancer Immunotherapy
Kyle B. Lupo et al.
CANCERS (2019)
A Comparison of Plasmid DNA and mRNA as Vaccine Technologies
Margaret A. Liu
VACCINES (2019)
Therapeutic Prospects of mRNA-Based Gene Therapy for Glioblastoma
Xiangjun Tang et al.
FRONTIERS IN ONCOLOGY (2019)
Intracellular delivery of mRNA to human primary T cells with microfluidic vortex shedding
Justin A. Jarrell et al.
SCIENTIFIC REPORTS (2019)
Microfluidic generation of transient cell volume exchange for convectively driven intracellular delivery of large macromolecules
Anna Liu et al.
MATERIALS TODAY (2018)
Intracellular Delivery of Nanomaterials via an Inertial Microfluidic Cell Hydroporator
Yanxiang Deng et al.
NANO LETTERS (2018)
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
S. L. Maude et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Viral and Nonviral Engineering of Natural Killer Cells as Emerging Adoptive Cancer Immunotherapies
Sandro Matosevic
JOURNAL OF IMMUNOLOGY RESEARCH (2018)
Efficient and Non-genotoxic RNA-Based Engineering of Human T Cells Using Tumor-Specific T Cell Receptors With Minimal TCR Mispairing
Diana Campillo-Davo et al.
FRONTIERS IN IMMUNOLOGY (2018)
Non-Viral Transfection of Human T Lymphocytes
Simon A. B. Riedl et al.
PROCESSES (2018)
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
S. S. Neelapu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Hit-and-run programming of therapeutic cytoreagents using mRNA nanocarriers
H. F. Moffett et al.
NATURE COMMUNICATIONS (2017)
High-throughput nuclear delivery and rapid expression of DNA via mechanical and electrical cell-membrane disruption
Xiaoyun Ding et al.
NATURE BIOMEDICAL ENGINEERING (2017)
Inheritable Silencing of Endogenous Genes by Hit-and-Run Targeted Epigenetic Editing
Angelo Amabile et al.
CELL (2016)
Clinical manufacturing of CAR T cells: foundation of a promising therapy
Xiuyan Wang et al.
MOLECULAR THERAPY-ONCOLYTICS (2016)
CD33-specific chimeric antigen receptor T cells exhibit potent preclinical activity against human acute myeloid leukemia
S. S. Kenderian et al.
LEUKEMIA (2015)
Genome editing at the crossroads of delivery, specificity, and fidelity
Ignazio Maggio et al.
TRENDS IN BIOTECHNOLOGY (2015)
Rigorous optimization and validation of potent RNA CAR T cell therapy for the treatment of common epithelial cancers expressing folate receptor
Keith Schutsky et al.
ONCOTARGET (2015)
Mesothelin-Specific Chimeric Antigen Receptor mRNA-Engineered T Cells Induce Antitumor Activity in Solid Malignancies
Gregory L. Beatty et al.
CANCER IMMUNOLOGY RESEARCH (2014)
Are natural killer cells superior CAR drivers?
Hans Klingemann
ONCOIMMUNOLOGY (2014)
T cell responses: naive to memory and everything in between
Nathan D. Pennock et al.
ADVANCES IN PHYSIOLOGY EDUCATION (2013)
A vector-free microfluidic platform for intracellular delivery
Armon Sharei et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Therapeutic Delivery of mRNA: The Medium Is the Message
R. Scott McIvor
MOLECULAR THERAPY (2011)
Cell Density Plays a Critical Role in Ex Vivo Expansion of T Cells for Adoptive Immunotherapy
Qiangzhong Ma et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2010)
Share Paper
